14.40MMarket Cap-2333P/E (Static)
0.007High0.007Low1.63MVolume0.007Open0.006Pre Close11.40KTurnover0.01152wk High0.12%Turnover Ratio2.06BShares0.00652wk Low-0.003EPS TTM9.78MFloat Cap0.619Historical HighLossP/E (Static)1.40BShs Float0.004Historical Low-0.003EPS LYR0.00%Amplitude--Dividend TTM3.50P/B1Lot Size--Div YieldTTM
Patrys Ltd Stock Forum
Delivery of GENE-EDITING constructs could be very lucrative for PAB . Something not priced in the share price regarding future potential.
Comment by PAB in 2022
Patrys could also become a pioneer in the emerging gene-editing
payload delivery space, giving it a lead in the gene therapy space, which is expected to see
1,500% growth by 2027, he added.
No comment yet